Peter Marks, the head of the FDA’s Center for Biologics Evaluation and Research and one of the agency’s highest-profile officials, has suddenly resigned amid a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
